[1]
Z. Uddin, S. Suleman, S. zeb, I. Ullah, and S. Zia, “EFFECTIVENESS OF COMBINATION THERAPY WITH SOFOSBUVIR AND DACLATASVIR IN HCV INFECTED PATIENTS”, JMS, vol. 28, no. 3, pp. 239–243, Oct. 2020.